News & partners

Dianosic is a biotech focused on the development of novel solutions integrated drug and
delivery system for the localized treatment of patients with chronic rhinitis and chronic rhinosinusitis.

Latest news

Apr 05, 2023

Dianosic x ‌La French Care

See more
Oct 29, 2021

101 Best France Medical Device Startups

See more
Sep 24, 2021

Dianosic at the ERS congress 2021

See more
Jul 08, 2021

What are the main causes of epistaxis?

See more
Apr 19, 2021

Snitem – Dianosic receives the public’s favorite award 2021

See more

They support us

Our investors

We built a solid network of partners to support company funding and growth.

Wiseed
Bpi France
Fondation Force
Eurométropole de Strasbourg
Banque Populaire Rives de Paris
Caisse d’épargne Grand Est
La Région Grand Est